Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
Background Renal sympathetic hyperactivity is associated with hypertension and its progression,
chronic kidney disease, and heart failure. We did a proof-of-principle trial of therapeutic …
chronic kidney disease, and heart failure. We did a proof-of-principle trial of therapeutic …
Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience
Background— Thromboembolism due to atrial fibrillation (AF) is a frequent cause of stroke.
More than 90% of thrombi in AF form in the left atrial appendage (LAA). Obliteration of the …
More than 90% of thrombi in AF form in the left atrial appendage (LAA). Obliteration of the …
Transcatheter closure of atrial septal defect and patent foramen ovale with the ASDOS device (a multi-institutional European trial)
H Sievert, UU Babic, G Hausdorf, M Schneider… - The American journal of …, 1998 - Elsevier
A clinical trial was conducted to assess the feasibility, safety, and efficacy of the atrial septal
defect (ASD) occlusion system for transcatheter closure of secundum ASD and patent …
defect (ASD) occlusion system for transcatheter closure of secundum ASD and patent …
Renal denervation with a percutaneous bipolar radiofrequency balloon catheter in patients with resistant hypertension: 6-month results from the REDUCE-HTN clinical …
H Sievert, J Schofer, J Ormiston, UC Hoppe… - … : journal of EuroPCR …, 2015 - europepmc.org
Aims To evaluate the safety and efficacy of the balloon-based bipolar Vessix Renal
Denervation System in treating patients with resistant hypertension. Methods and results In this …
Denervation System in treating patients with resistant hypertension. Methods and results In this …
Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial
DR Holmes, VY Reddy, ZG Turi, SK Doshi, H Sievert… - The Lancet, 2009 - thelancet.com
Background In patients with non-valvular atrial fibrillation, embolic stroke is thought to be
associated with left atrial appendage (LAA) thrombi. We assessed the efficacy and safety of …
associated with left atrial appendage (LAA) thrombi. We assessed the efficacy and safety of …
Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the …
…, S Kar, MJ Price, B Whisenant, H Sievert… - Journal of the American …, 2014 - jacc.org
Background : In the PROTECT AF (Watchman Left Atrial Appendage Closure Technology
for Embolic Protection in Patients With Atrial Fibrillation) trial that evaluated patients with …
for Embolic Protection in Patients With Atrial Fibrillation) trial that evaluated patients with …
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral …
…, V Riambau, M Roffi, J Röther, H Sievert… - European heart …, 2011 - academic.oup.com
Cardiovascular diseases (CVDs) are the leading cause of death and disability in Europe,
posing a great social and economic burden. Coronary artery disease (CAD) is the cause of …
posing a great social and economic burden. Coronary artery disease (CAD) is the cause of …
Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval …
…, J Hausleiter, C Butter, GP Ussia, H Sievert… - Journal of the American …, 2013 - jacc.org
Objectives : The purpose of this article is to report early and mid-term outcomes of the ACCESS-EU
study (ACCESS-Europe A Two-Phase Observational Study of the MitraClip System in …
study (ACCESS-Europe A Two-Phase Observational Study of the MitraClip System in …
Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial
VY Reddy, H Sievert, J Halperin, SK Doshi… - Jama, 2014 - jamanetwork.com
Importance While effective in preventing stroke in patients with atrial fibrillation (AF), warfarin
is limited by a narrow therapeutic profile, a need for lifelong coagulation monitoring, and …
is limited by a narrow therapeutic profile, a need for lifelong coagulation monitoring, and …
Editor's Choice–2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery …
…, MF Piepoli, D Scheinert, H Sievert… - European Journal of …, 2018 - ejves.com
… Katus, Juhani Knuuti, Jes Lindholt, Heinrich Mattle, Piotr Pieniazek, Massimo Francesco
Piepoli, Dierk Scheinert, Horst Sievert, Iain Simpson, Jakub Sulzenko, Juan Tamargo, Lale …
Piepoli, Dierk Scheinert, Horst Sievert, Iain Simpson, Jakub Sulzenko, Juan Tamargo, Lale …